Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis
-
Published:2024-06
Issue:6
Volume:24
Page:382-391.e2
-
ISSN:2152-2650
-
Container-title:Clinical Lymphoma Myeloma and Leukemia
-
language:en
-
Short-container-title:Clinical Lymphoma Myeloma and Leukemia
Author:
Chavez Julio C,
Grajales ArielORCID,
Sandoval-Sus JoseORCID,
Turba Elyce,
Nodzon Lisa,
Uriepero-Palma Angimar,
Ammad-Ud-Din Mohammad,
Sahakian EvaORCID,
Komrokji Rami,
Sokol Lubomir,
Locke Frederick L,
Shah Bijal,
Lancet Jeffrey,
Sotomayor Eduardo M,
Kharfan-Dabaja Mohamed A.ORCID,
Bello Celeste,
Pinilla-Ibarz Javier